Translational Medicine in Fish-derived Peptides: From Fish Endocrinology to Human Physiology and Diseases

Endocrine Journal

Volumn 51, Issue 1, 2004, Pages 1-17

  Takahashi, Kazuhiro ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular; Melanin concentrating hormone; Neuropeptide; Urocortin; Urotensin

Indexed keywords

ALPHA INTERMEDIN; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BETA INTERMEDIN; COMPLEMENTARY DNA; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; LIGAND; MELANIN CONCENTRATING HORMONE; MESSENGER RNA; NEUROPEPTIDE; NITRIC OXIDE; SNAP 7941; UNCLASSIFIED DRUG; UROCORTIN; UROTENSIN I; UROTENSIN II;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FISH; GENE EXPRESSION; HEMODIALYSIS; HUMAN; NEUROENDOCRINOLOGY; NONHUMAN; PROLIFERATIVE GLOMERULONEPHRITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHEUMATOID ARTHRITIS; TUMOR GROWTH;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DISEASE; FISHES; HUMANS; HYPOTHALAMIC HORMONES; MELANINS; PITUITARY HORMONES; UROTENSINS;

EID: 1642463375     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.51.1     Document Type: Review

References (159)

1. Takahashi K (2001) Adrenomedullin from a pheochromocytoma to the eye: implications of the adrenomedullin research for endocrinology in the 21st century. Tohoku J Exp Med 193: 79-114. Review.
2. Burgus R, Guillemin R (1970) Hypothalamic releasing factors. Annu Rev Biochem 39: 499-526.
3. Schally AV, Arimura A, Kastin AJ (1973) Hypothalamic regulatory hormones. Science 179: 341-350.
4. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213: 1394-1397.
5. Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y - A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659-660.
6. Kangawa K, Matsuo H (1984) Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Comm 118:, 131-139.
7. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
8. Takahashi K (2001) Adrenomedullin: from a pheochromocytoma to the eyes. Peptides 22: 1691.
9. Eto T (2001) A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 22: 1693-1711. Review.
10. Tomoda Y, Isumi Y, Katafuchi T, Minamino N (2001) Regulation of adrenomedullin secretion from cultured cells. Peptides 22: 1783-1794.
11. Nakayama M, Takahashi K, Murakami O, Murakami H, Sasano H, Shirato K, Shibahara S (1999) Adrenomedullin in monocytes and macrophages: possible involvement of macrophage-derived adrenomedullin in atherogenesis. Clin Sci (Lond) 97: 247-251.
12. Takahashi K, Nakayama M, Totsune K, Murakami O, Sone M, Kitamuro T, Yoshinoya A, Shibahara S (2000) Increased secretion of adrenomedullin from cultured human astrocytes by cytokines. J Neurochem 74: 99-103.
13. Udono T, Takahashi K, Nakayama M, Yoshinoya A, Totsune K, Murakami O, Durlu YK, Tamai M, Shibahara S (2001) Induction of adrenomedullin by hypoxia in cultured retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 42: 1080-1086.
14. Udono T, Takahashi K, Nakayama M, Murakami O, Durlu YK, Tamai M, Shibahara S (2000) Adrenomedullin in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 41: 1962-1970.
15. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, Abe K, Miura Y, Hayashi Y, Sasano H, Mouri T (1995) Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J Clin Endocrinol Metab 80: 1750-1752.
16. Miller MJ, Martinez A, Unsworth EJ, Thiele CJ, Moody TW, Elsasser T, Cuttitta F (1996) Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem 271: 23345-23351.
17. Takahashi K, Satoh F, Hara E, Sone M, Murakami O, Kayama T, Yoshimoto T, Shibahara S (1997) Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP productlon. Peptides 18:1117-1124.
18. Nakayama M, Takahashi K, Murakami O, Shirato K, Shibahara S (1998) Induction of adrenomedullin by hypoxia and cobalt chloride in human colorectal carcinoma cells. Biochem Biophys Res Comm 243: 514-517.
19. Takahashi K, Satoh F, Sone M, Totsune K, Arihara Z, Noshiro T, Mouri T, Murakami O (1998) Expression of adrenomedullin mRNA in adrenocortical tumors and secretion of adrenomedullin by cultured adrenocortical carcinoma cells. Peptides 19: 1719-1724.
20. Takahashi K, Totsune K, Kitamuro T, Sone M, Murakami O, Shibahara S (2002) Three vasoactive peptides, endothelin-1, adrenomedullin and urotensin-II, in human tumour cell lines of different origin: expression and effects on proliferation. Clin Sci (Lond) 103 (Suppl 48): 35S-38S.
21. Takahashi K, Totsune K, Murakami O (2002) Adrenocortical peptides: autocrine or paracrine regulators for the steroid hormone secretion or the cell proliferation? Exp Clin Endocrinol Diabetes 110: 373-380.
22. Kawauchi H, Kawazoe I, Tsubokawa M, Kishida M, Baker BI (1983) Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature 305:321-323.
23. Lederis K, Letter A, McMaster D, Ichikawa T, MacCannell KL, Kobayashi Y, Rivier J, Rivier C, Vale W, Fryer J (1983) Isolation, analysis of structure, synthesis, and biological actions of urotensin I neuropeptides. Can J Biochem Cell Biol 61: 602-614.
24. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287-292.
25. Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, Beauvillain JC, Conlon JM, Bern HA, Vaudry H (1998) Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95: 15803-15808.
26. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Ohlstein EH, Bergsma DJ, Douglas SA (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401:282-286.
27. Hogben L I, Slome D (1931) The pigmentary effector system. VI. The dual character of endocrine coordination in amphibian colour change. Proc R Soc London SerB 108: 10-53.
28. Naito N, Nakai Y, Kawauchi H, Hayashi Y (1985) Immunocytochemical identification of melanin-concentrating hormone in the brain and pituitary gland of the teleost fishes Oncorhynchus-keta and Salmo-gairdneri. Cell Tissue Res 242: 41-48.
29. Bird DJ, Baker BI, Kawauchi H (1989) Immunocytochemical demonstration of melanin-concentrating hormone and proopiomelanocortin-like products in the brain of the trout and carp. Gen Comp Endocrinol 74: 442-450.
30. Eberle AN, Baker BI, Kishida M, Baumann JB, Girard J (1989) Melanin concentrating hormone. IV. Development of a sensitive solid-phase radioimmunoassay for melanin-concentrating hormone. Life Sci 45: 1149-1154.
31. Kishida M, Baker BI, Eberle AN (1989) The measurement of melanin-concentrating hormone in trout blood. Gen Comp Endocrinol 74: 221-229.
32. Green JA, Baker BI (1991) The influence of repeated stress on the release of melanin-concentrating hormone in the rainbow trout. J Endocrinol 128: 261-266.
33. Green JA, Baker BI, Kawauchi H (1991) The effect of rearing rainbow trout on black or white backgrounds on their secretion of melanin-concentrating hormone and their sensitivity to stress. J Endocrinol 128: 267-274.
34. Baker BI, Bird DJ, Buckingham JC (1985) Salmonid melanin-concentrating hormone inhibits corticotrophin release. J Endocrinol 106: R5-8.
35. Baker BI, Bird DJ, Buckingham JC (1986) Effects of chronic administration of melanin-concentrating hormone on corticotrophin, melanotrophin, and pigmentation in the trout. Gen Comp Endocrinol 63: 62-69.
36. Vaughan JM, Fischer WH, Hoeger C, Rivier J, Vale W (1989) Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology 125: 1660-1665.
37. Nahon JL, Presse F, Bittencourt JC, Sawchenko PE, Vale W (1989) The rat melanin-concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. Endocrinology 125: 2056-2065.
38. Presse F, Nahon JL, Fischer WH, Vale W (1990) Structure of the human melanin concentrating hormone mRNA. Mol Endocrinol 4: 632-637.
39. Zamir N, Skofitsch G, Bannon MJ, Jacobowitz DM (1986) Melanin-concentrating hormone: unique peptide neuronal system in the rat brain and pituitary gland. Proc Natl Acad Sci USA 83: 1528-1531.
40. Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon JL, Vale W, Sawchenko PE (1992) The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 319: 218-245.
41. Presse F, Hervieu G, Imaki T, Sawchenko PE, Vale W, Nahon JL (1992) Rat melanin-concentrating hormone messenger ribonucleic acid expression: marked changes during development and after stress and glucocorticoid stimuli. Endocrinology 131: 1241-1250.
42. Pelletier G, Guy J, Desy L, Li S, Eberle AN, Vaudry H (1987) Melanin-concentrating hormone (MCH) is colocalized with alpha-melanocyte-stimulating hormone (alpha-MSH) in the rat but not in the human hypothalamus. Brain Res 423: 247-253.
43. Bresson JL, Clavequin MC, Fellmann D, Bugnon C (1989) Human hypothalamic neuronal system revealed with a salmon melanin-concentrating hormone (MCH) antiserum. Neurosci Lett 102: 39-43.
44. Mouri T, Takahashi K, Kawauchi H, Sone M, Totsune K, Murakami O, Itoi K, Ohneda M, Sasano H, Sasano N (1993) Melanin-concentrating hormone in the human brain. Peptides 14: 643-646.
45. Takahashi K, Mouri T, Totsune K, Sone M, Murakami O, Itoi K, Ohneda M, Sasano H, Sasano N, Kawauchi H (1993) Human melanin-concentrating hormone in the human brain. Ann NY Acad Sci 680: 619-620.
46. Takahashi K, Suzuki H, Totsune K, Murakami O, Satoh F, Sone M, Sasano H, Mouri T, Shibahara S (1995) Melanin-concentrating hormone in human and rat. Neuroendocrinology 61: 493-498.
47. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R, Maratos-Flier E (1996) A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380: 243-247.
48. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E (1998) Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396: 670-674.
49. Knigge KM, Baxter-Grillo D, Speciale J, Wagner J (1996) Melanotropic peptides in the mammalian brain: the melanin-concentrating hormone. Peptides 17: 1063-1073.
50. Knigge KM, Wagner JE (1997) Melanin-concentrating hormone (MCH) involvement in pentylenetetrazole (PTZ)-induced seizure in rat and guinea pig. Peptides 18:1095-1097.
51. Jezova D, Bartanusz V, Westergren I, Johansson BB, Rivier J, Vale W, Rivier C (1992) Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. Endocrinology 130:1024-1029.
52. Navarra P, Tsagarakis S, Coy DH, Rees LH, Besser GM, Grossman AB (1990) RAt melanin: concentrating hormone does not modify the release of CRH-4.1 from rat hypothalamus or ACTH from the anterior pituitary in vitro. J Endocrinol. 127:R1-4.
53. Gonzalez, MI, Baker BI, Wilson CA (1997) Stimulatory effect of melanin-concentrating hormone on luteinising hormone release. Neuroendocrinology 66: 254-262
54. Chiocchio SR, Gallardo MG, Louzan P, Gutnisky V, Tramezzani JH (2001) Melanin-concentrating hormone stimulates the release of luteinizing hormone-releasing hormone and gonadotropins in the female rat acting at both median eminence and pituitary levels. Biol Reprod 64: 1466-1472.
55. Gonzalez MI, Vaziri S, Wilson CA (1996) Behavioral effects of alpha-MSH and MCH after central administration in the female rat. Peptides 17: 171-177.
56. Tsukamura H, Thompson RC, Tsukahara S, Ohkura S, Maekawa F, Moriyama R, Niwa Y, Foster DL, Maeda K (2000) Intracerebroventricular administration of melanin-concentrating hormone suppresses pulsatile luteinizing hormone release in the female rat. J Neuroendocrinol 12: 529-534.
57. Kennedy AR, Todd JF, Stanley SA, Abbott CR, Small CJ, Ghatei MA, Bloom SR (2001) Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH) release, in vivo and in vitro, via the hypothalamus and the pituitary. Endocrinology 142: 3265-3268.
58. Monzon ME, de Souza MM, Izquierdo LA, Izquierdo I, Barros DM, de Barioglio SR (1999) Melanin-concentrating hormone (MCH) modifies memory retention in rats. Peptides 20: 1517-1519.
59. Bradley RL, Kokkotou EG, Maratos-Flier E, Cheatham B (2000) Melanin-concentrating hormone regulates leptin synthesis and secretion in rat adipocytes. Diabetes 49:1073-1077.
60. Bradley RL, Mansfield JP, Maratos-Flier E, Cheatham B (2002) Melanin-concentrating hormone activates signaling pathways in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 283: E584-592.
61. Stricker-Krongrad A, Dimitrov T, Beck B (2001) Central and peripheral dysregulation of melanin-concentrating hormone in obese Zucker rats. Brain Res Mol Brain Res 92: 43-48.
62. Chambers J, Ames RS, Bergsma D, Muir A, Fitzgerald LR, Hervieu G, Dytko GM, Foley JJ, Martin J, Liu WS, Park J, Ellis C, Ganguly S, Konchar S, Cluderay J, Leslie R, Wilson S, Sarau HM (1999) Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature 400: 261-265.
63. Saito Y, Nothacker HP, Wang Z, Lin SH, Leslie F, Civelli O (1999) Molecular characterization of the melanin-concentrating-hormone receptor. Nature 400: 265-269.
64. Shimomura Y, Mori M, Sugo T, Ishibashi Y, Abe M, Kurokawa T, Onda H, Nishimura O, Sumino Y, Fujino M (1999) Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. Biochem Biophys Res Comm 261: 622-626
65. Bachner D, Kreienkamp H, Weise C, Buck F, Ritcher D, (1999) Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett 457: 522-524
66. Lembo PM, Grazzini E, Cao J, Hubatsch DA, Pelletier M, Hoffert C, St-Onge S, Pou C, Labrecque J, Groblewski T, O'Donnell D, Payza K, Ahmad S, Walker P (1999) The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nat Cell Biol 1: 267-271.
67. Ludwig DS, Mountjoy KG, Tatro JB, Gillette JA, Frederich RC, Flier JS, Maratos-Flier E (1998) Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am J Physiol 274: E627-633.
68. Takahashi K, Totsune K, Murakami O, Sone M, Satoh F, Kitamuro T, Noshiro T, Hayashi Y, Sasano H, Shibahara S (2001) Expression of melanin-concentrating hormone receptor messenger ribonucleic acid in tumor tissues of pheochromocytoma, ganglioneuroblastoma, and neuroblastoma. J Clin Endocrinol Metab 86:369-374.
69. An S, Cutler G, Zhao JJ, Huang SG, Tian H, Li W, Liang L, Rich M, Bakleh A, Du J, Chen JL, Dai K (2001) Identification and characterization of a melanin-concentrating hormone receptor. Proc Natl Acad Sci USA 98: 7576-7581.
70. Hill J, Duckworth M, Murdock P, Rennie G, Sabido-David C, Ames RS, Szekeres P, Wilson S, Bergsma DJ, Gloger IS, Levy DS, Chambers JK, Muir Al (2001) Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. J Biol Chem 276:20125-20129.
71. Wang S, Behan J, O'Neill K, Weig B, Fried S, Laz T, Bayne M, Gustafson E, Hawes BE (2001) Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, MCH-R2. J Biol Chem 276: 34664-34670.
72. Sailer AW, Sano H, Zeng Z, McDonald TP, Pan J, Pong SS, Feighner SD, Tan CP, Fukami T, Iwaasa H, Hreniuk DL, Morin NR, Sadowski SJ, Ito M, Ito M, Bansal A, Ky B, Figueroa DJ, Jiang Q, Austin CP, MacNeil DJ, Ishihara A, Ihara M, Kanatani A, Van der Ploeg LH, Howard AD, Liu Q (2001) Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc Natl Acad Sci USA 98:7564-7569.
73. Mori M, Harada M, Terao Y, Sugo T, Watanabe T, Shimomura Y, Abe M, Shintani Y, Onda H, Nishimura O, Fujino M (2001) Cloning of a novel G protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor. Biochem Biophys Res Comm 283: 1013-1018.
74. Rodriguez M, Beauverger P, Naime I, Rique H, Ouvry C, Souchaud S, Dromaint S, Nagel N, Suply T, Audinot V, Boutin JA, Galizzi JP (2001) Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2. Mol Pharmacol 60: 632-639.
75. Sone M, Takahashi K, Murakami O, Totsune K, Arihara Z, Satoh F, Sasano H, Ito H, Mouri T (2000) Binding sites for melanin-concentrating hormone in the human brain. Peptides 21: 245-250.
76. Marsh DJ, Weingarth DT, Novi DE, Chen HY, Trumbauer ME, Chen AS, Guan XM, Jiang MM, Feng Y, Camacho RE, Shen Z, Frazier EG, Yu H, Metzger JM, Kuca SJ, Shearman LP, Gopal-Truter S, MacNeil DJ, Strack AM, MacIntyre DE, Van der Ploeg LH, Qian S (2002) Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci USA 99: 3240-3245.
77. Chen Y, Hu C, Hsu CK, Zhang Q, Bi C, Asnicar M, Hsiung HM, Fox N, Slieker LJ, Yang DD, Heiman ML, Shi Y (2002) Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology 143: 2469-2477.
78. Takekawa S, Asami A, Ishihara Y, Terauchi J, Kato K, Shimomura Y, Mori M, Murakoshi H, Kato K, Suzuki N, Nishimura O, Fujino M (2002) T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eur J Pharmacol 438: 129-135.
79. Bednarek MA, Hreniuk DL, Tan C, Palyha OC, Mac-Neil DJ, Van der Ploeg LH, Howard AD, Feighner SD (2002) Synthesis and biological evaluation in vitro of selective, high affinity peptide antagonists of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1. Biochemistry 41:6383-6390.
80. Borowsky B, Durkin MM, Ogozalek K, Marzabadi MR, DeLeon J, Lagu B, Heurich R, Lichtblau H, Shaposhnik Z, Daniewska I, Blackburn TP, Branchek TA, Gerald C, Vaysse PJ, Forray C (2002) Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 I receptor antagonist. Nat Med 8: 825-830.
81. Bednarek MA, Tan C, Hreniuk DL, Palyha OC, MacNeil DJ, Van Der Ploeg LH, Howard AD, Feighner SD (2002) Synthesis and biological evaluation in vitro of a selective, high potency peptide agonist of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1. J Biol Chem 277: 13821-13826.
82. Emani M (1959) The morphology and functional significance of the caudal neurosecretory system of fishes. In: Gorbman A (ed) Comparative Endocrinology. Wiley, New York, 697-724.
83. Moore G, Letter A, Tesanovic M, Lederis K (1975) Studies on molecular weights of two peptide hormones from the urophysis of white sucker (Catostomus commersoni). Can J Biochem 53: 242-247.
84. Chan DK, Bern HA (1976) The caudal neurosecretory system. A critical evaluation of the two-hormone hypothesis. Cell Tissue Res 174: 339-354. Review.
85. Lederis K, Letter A, McMaster D, Moore G, Schlesinger D (1982) Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus. Science 218: 162-165.
86. Pearson D, Shively JE, Clark BR, Geschwind II, Barkley M, Nishioka RS, Bern HA (1980) Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci USA 77: 5021-5024.
87. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW (1996) Cloning and characterization of human urocortin. Endocrinology 137: 2167-2170.
88. Takahashi K, Totsune K, Sone M, Murakami O, Satoh F, Arihara Z, Sasano H, Iino K, Mouri T (1998) Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides 19: 643-647.
89. Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Totsune K, Takahashi K, Suzuki H, Nagura H, Yoshimi T (1997) Urocortin expression in human pituitary gland and pituitary adenoma. J Clin Endocrinol Metab 82: 3842-3850.
90. Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Takahashi K, Suzuki H, Tezuka F, Yoshimi T, Nagura H (1999) Urocortin expression in the human central nervous system. Clin Endocrinol (Oxf) 50: 107-114.
91. Harada S, Imaki T, Naruse M, Chikada N, Nakajima K, Demura H (1999) Urocortin mRNA is expressed in the enteric nervous system of the rat. Neurosci Lett 267: 125-128.
92. Muramatsu Y, Fukushima K, Iino K, Totsune K, Takahashi K, Suzuki T, Hirasawa G, Takeyama J, Ito M, Nose M, Tashiro A, Hongo M, Oki Y, Nagura H, Sasano H (2000) Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 21: 1799-1809.
93. Petraglia F, Florio P, Gallo R, Simoncini T, Saviozzi M, Di Blasio AM, Vaughan J, Vale W (1996) Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab 81: 3807-3810.
94. Muramatsu Y, Sugino N, Suzuki T, Totsune K, Takahashi K, Tashiro A, Hongo M, Oki Y, Sasano H (2001) Urocortin and corticotropin-releasing factor receptor expression in norma cycling human ovaries. J Clin Endocrinol Metab 86:1362-1369.
95. Florio P, Arcuri F, Ciarmela P, Runci Y, Romagnoli R, Cintorino M, Di Blasio AM, Petraglia (2002) Identification of urocortin mRNA and peptide in the human endometrium. J Endocrinol 173: R9-14.
96. Uzuki M, Sasano H, Muramatsu Y, Totsune K, Takashi K, Oki Y, Iino K, Sawai T (2001) Urocortin in the synovial tissue of patients with rheumatoid arthritis. Clin Sci (Lond) 100:577-589.
97. Bamberger CM, Wald M, Bargerger AM, Ergun S, Beil FU, Schulte HM (1998) Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J Clin Endocrinol Metab 83: 708-711.
98. Chen R, Lewis KA, Perrin MH, Vale WW (1993) Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90: 8967-8971.
99. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T (1995) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92: 836-840.
100. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19: 162-166.
101. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP (2000) Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 24: 403-409.
102. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF (2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24: 410-414.
103. Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F, Hermanson O, Rosenfeld MG, Spiess J (2000) Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 24: 415-419.
104. Parkes DG, Vaughan J, Rivier J, Vale W, May CN (1997) Cardiac inotropic actions of urocortin in conscious sheep. Am J Physiol 272: H2115-2122.
105. Parkes DG, Weisinger RS, May CN (2001) Cardiovascular actions of CRH and urocortin: an update. Peptides 22: 821-827. Review.
106. Terui K, Higashiyama A, Horiba N, Furukawa KI, Motomura S, Suda T (2001) Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart. J Endocrinol 169: 177-183.
107. Okosi A, Brar BK, Chan M, D'Souza L, Smith E, Stephanou A, Latchman DS, Chowdrey HS, Knight RA (1998) Expression and Protective effects of urocortin in cardiac myocytes. Neuropeptides 32: 167-171.
108. Brar BK, Stephanou A, Okosi A, Lawrence KM, Knight RA, Marber MS, Latchman DS (1999) CRH-like peptides protect cardiac myocytes from lethal ischaemic injury. Mol Cell Endocrinol 158: 55-63.
109. Brar BK, Jonassen AK, Stephanou A, Santilli G, Railson J, Knight RA, Yellon DM, Latchman DS (2000) Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J Biol Chem 275: 8508-8514.
110. Brar BK, Stephanou A, Knight R, Latchman DS (2002) Activation of protein kinase B/Akt: by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. J Mol Cell Cardiol 34: 483-492.
111. Lawrence KM, Chanalaris A, Scarabelli T, Hubank M, Pasini E, Townsend PA, Comini L, Ferrari R, Tinker A, Stephanou A, Knight RA, Latchman DS (2002) K (ATP) channel gene expression is induced by urocortin and mediates its cardioprotective effect. Circulation 106:1556-1562.
112. Schulman D, Latchman DS, Yellon DM (2002) Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am J Physiol Heart Circ Physiol 283: H1481-1488.
113. Scarabelli TM, Pasini E, Stephanou A, Comini L, Curello S, Raddino R, Ferrari R, Knight R, Latchman DS (2002) Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion. JAm Coll Cardiol 40:155-161.
114. Ikeda K, Tojo K, Sato S, Ebisawa T, Tokudome G, Hosoya T, Harada M, Nakagawa O, Nakao K (1998) Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes. Biochem Biophys Res Comm 250: 298-304.
115. Heldwein KA, Redick DL, Rittenberg MB, Claycomb WC, Stenzel-Poore MP (1996) Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells. Endocrinology 137: 3631-3639.
116. Samson WK (1996) "Here the heart may give a useful lesson to the head". Endocrinology 137: 3629-3630.
117. Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H (2002) Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab 87: 340-346.
118. Nishikimi T, Miyata A, Horio T, Yoshihara F, Nagaya N, Takishita S, Yutani C, Matsuo H, Matsuoka H, Kangawa K (2000) Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. Am J Physiol Heart Circ Physiol 279: H3031-3039.
119. Rademaker MT, Charles CJ, Espiner EA, Fisher S, Frampton CM, Kirkpatrick CM, Lainchbury JG, Nicholls MG, Richards AM, Vale WW (2002) Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. J Am Coll Cardiol 40: 1495-1505.
120. Baigent SM (2001) Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 22: 809-820. Review.
121. Kageyama K, Bradbury MJ, Zhao L, Blount AL, Vale WW (1999) Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 140:5651-5658.
122. Chatzaki E, Charalampopoulos I, Leontidis C, Mouzas IA, Tzardi M, Tsatsanis C, Margioris AN, Gravanis A (2003) Urocortin in human gastric mucosa: relationship to inflammatory activity. J Clin Endocrinol Metab 88: 478-483.
123. Oki Y, Iwabuchi M, Masuzawa M, Watanabe F, Ozawa M, Iino K, Tominaga T, Yoshimi T (1998) Distribution and concentration of urocortin, and effect of adrenalectomy on its content in rat hypothalamus. Life Sci 62: 807-812.
124. Poliak S, Mor F, Conlon P, Wong T, Ling N, Rivier J, Vale W, Steinman L (1997) Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. J Immunol 158: 5751-5756.
125. Okamoto S, Ishikawa I, Kimura K, Saito M (1998) Potent suppressive effects of urocortin on splenic lymphocyte activity in rats. Neuroreport 9: 4035-4039.
126. Singh LK, Boucher W, Pang X, Letourneau R, Seretakis D, Green M, Theoharides TC (1999) Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J Pharmacol Exp Ther 288:1349-1356.
127. Wang X, Su H, Copenhagen LD, Vaishnav S, Pieri F, Shope CD, Brownell WE, De Biasi M, Paylor R, Bradley A (2002) Urocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle response. Mol Cell Biol 22: 6605-6610.
128. Vetter DE, Li C, Zhao L, Contarino A, Liberman MC, Smith GW, Marchuk Y, Koob GF, Heinemann SF, Vale W, Lee KF (2002) Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat Genet 31: 363-369.
129. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98: 2843-2848.
130. Hsu SY, Hsueh AJ (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7: 605-611.
131. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570-7575.
132. Dautzenberg FM, Hauger RL (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23: 71-77. Review.
133. Li C, Vaughan J, Sawchenko PE, Vale WW (2002) Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 22: 991-1001.
134. Berlind A (1972) Teleost caudal neurosecretory system: release of urotensin II from isolated urophyses. Gen Comp Endocrinol 18: 557-560.
135. MacLean MR, Alexander D, Stirrat A, Gallagher M, Douglas SA, Ohlstein EH, Morecroft I, Polland K (2000) Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat. Br d J Pharmacol 130:201-204.
136. Bottrill FE, Douglas SA, Hiley CR, White R (2000) Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol 130: 1865-1870.
137. Stirrat A, Gallagher M, Douglas SA, Ohlstein EH, Berry C, Kirk A, Richardson M, MacLean MR (2001) Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries. Am J Physiol Heart Circ Physiol 280: H925-928.
138. Russell FD, Molenaar P, O'Brien DM (2001) Cardiostimulant effects of urotensin-II in human heart in vitro. Br J Pharmacol 132: 5-9.
139. Watanabe T, Pakala R, Katagiri T, Benedict CR (2001) Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104: 16-18.
140. Watanabe T, Pakala R, Katagiri T, Benedict CR (2001) Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation. J Hypertens 19:2191-2196.
141. Sauzeau V, Le Mellionnec E, Bertoglio J, Scalbert E, Pacaud P, Loirand G (2001) Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res 88: 1102-1104.
142. Zou Y, Nagai R, Yamazaki T (2001) Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats. FEBS Lett 508: 57-60.
143. Silvestre RA, Rodriguez-Gallardo J, Egido EM, Marco J (2001) Inhibition of insulin release by urotensin II - a study on the perfused rat pancreas. Horm Metab Res 33:379-381.
144. Totsune K, Takahashi K, Arihara Z, Sone M, Satoh F, Ito S, Kimura Y, Sasano H, Murakami O. (2001) Role of urotensin II in patients on dialysis. Lancet 358: 810-811.
145. Matsushita M, Shichiri M, Imai T, Iwashima M, Tanaka H, Takasu N, Hirata Y (2001) Co-expression urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19: 2185-2190.
146. Shenouda A, Douglas SA, Ohlstein EH, Giaid A (2002) Localization of urotensin-II immunoreactivity in normal human kidneys and renal carcinoma. J Histochem Cytochem 50: 885-889.
147. Richards AM, Nicholls MG, Lainchbury JG, Fisher S, Yandle TG (2002) Plasma urotensin II in heart failure. Lancet 360: 545-546.
148. Ng LL, Loke I, O'Brien RJ, Squire IB, Davies JE (2002) Plasma urotensin in human systolic heart failure. Circulation 106: 2877-2880.
149. Heller J, Schepke M, Neef M, Woitas R, Rabe C, Sauerbruch T (2002) Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension. J Hepatol 37: 767-772.
150. Totsune K, Takahashi K, Arihara Z, Sone M, Ito S, Murakami O (2003) Increased plasma urotensin II levels in patients with diabetes mellitus. Clin Sci (Lond) 104: 1-5.
151. Douglas SA, Tayara L, Ohlstein EH, Halawa N, Giaid A (2002) Congestive heart failure and expression of myocardial urotensin II. Lancet 359: 1990-1997.
152. Zhu F, Ji L, Luo B (2002) The role of urotensin II gene in the genetic susceptibility to type 2 diabetes in Chinese population. Zhonghua Yi Xue Za Zhi 82: 1473-1475.
153. Wenyi Z, Suzuki S, Hirai M, Hinokio Y, Tanizawa Y, Matsutani A, Satoh J, Oka Y (2003) Role of urotensin II gene in genetic susceptibility to type 2 diabetes mellitus in Japanese subjects. Diabetologia 46: 972-976.
154. Dschietzig T, Bartsch C, Pregla R, Zurbrugg HR, Armbruster FP, Richter C, Laule M, Romeyke E, Neubert C, Voelter W, Baumann G, Stangl K (2002) Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure. Regul Pept 110: 33-38.
155. Takahashi K, Totsune K, Murakami O, Shibahara S (2001) Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells. Peptides 22: 1175-1179.
156. Takahashi K, Totsune K, Murakami O (2001) Expression of three vasoactive peptides, urotensin-II, adrenomedullin and endothelin-1, in a human renal cell carcinoma cell line, VMRC-RCW. Clin Exp Nephrol 5: 246-249.
157. Takahashi K, Totsune K, Murakami O, Arihara Z, Noshiro T, Hayashi Y, Shibahara S (2003) Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II. Peptides 24: 301-306.
158. Ziltener P, Mueller C, Haenig B, Scherz MW, Nayler O (2002) Urotensin II mediates ERK1/2 phosphorylation GPR14-transfected cell lines. J Recept Signal Transduct Res 22: 155-168.
159. Conlon JM (2000) Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research. Regul Pept 93: 3-12. Review.